Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Recurrence 1Rectal Neoplasms 1Neoplasms 1Motor Activity 1Lymphoma 1Leukemia, B-Cell 1Glioma 1Glioblastoma 1Colorectal Cancer Prevention 1Colonic Neoplasms 1Anastomotic Leak 1

Interventions

Bevacizumab 56Cetuximab 50Fluorouracil 45Leucovorin 39Oxaliplatin 38pembrolizumab 31Specimen Handling 27Irinotecan 25Magnetic Resonance Spectroscopy 17Biopsy 17Nivolumab 15HMPL-013 13Folfox protocol 13Capecitabine 13Gemcitabine 12Cisplatin 12trifluridine tipiracil drug combination 11Panitumumab 11Carboplatin 11Pemetrexed 9IFL protocol 9encorafenib 8balstilimab 8Standard of Care 8Paclitaxel 8Early Intervention, Educational 8130-nm albumin-bound paclitaxel 8fludarabine 7atezolizumab 7Educational Status 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Colorectal Neoplasms × Diet × 90 days × Clear all
NCT06827366 2026-05-05

LIFE-SCREEN

Centre Leon Berard

Phase NA Recruiting
800 enrolled
Gastrointestinal

Motor Activity, Colorectal Neoplasms

NCT07494201 2026-03-27

MIMICC

Fondazione del Piemonte per l'Oncologia

Phase NA Recruiting
2,500 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡